Samuel J. Reich - CEO & EXECUTIVE CHAIRMAN, Director at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO & EXECUTIVE CHAIRMAN, Director
Stock Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Samuel J. Reich - trading volume in the past year for SAB Biotherapeutics, Inc.

Holdings reported by Samuel J. Reich for SAB Biotherapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 548 K $482 K $0.88 Nov 29, 2023 Via Big Cypress Holdings LLC
Common Stock 219 K $193 K $0.88 Nov 29, 2023 Direct
Employee Stock Option (right to buy) 434 K Feb 21, 2024 Direct Common Stock
Warrants 9.97 K Feb 28, 2023 Direct Common Stock
Warrants 0 Feb 28, 2023 Via Big Cypress Holdings LLC Common Stock

Transactions reported by Samuel J. Reich for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership